These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
408 related items for PubMed ID: 12697885
1. Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for Neuroblastoma. De Bernardi B, Nicolas B, Boni L, Indolfi P, Carli M, Cordero Di Montezemolo L, Donfrancesco A, Pession A, Provenzi M, di Cataldo A, Rizzo A, Tonini GP, Dallorso S, Conte M, Gambini C, Garaventa A, Bonetti F, Zanazzo A, D'Angelo P, Bruzzi P, Italian Co-Operative Group for Neuroblastoma. J Clin Oncol; 2003 Apr 15; 21(8):1592-601. PubMed ID: 12697885 [Abstract] [Full Text] [Related]
4. Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol. Valteau-Couanet D, Michon J, Boneu A, Rodary C, Perel Y, Bergeron C, Rubie H, Coze C, Plantaz D, Bernard F, Chastagner P, Bouzy J, Hartmann O. J Clin Oncol; 2005 Jan 20; 23(3):532-40. PubMed ID: 15659499 [Abstract] [Full Text] [Related]
5. Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma. Kushner BH, Kramer K, LaQuaglia MP, Modak S, Yataghene K, Cheung NK. J Clin Oncol; 2004 Dec 15; 22(24):4888-92. PubMed ID: 15611504 [Abstract] [Full Text] [Related]
7. [Curative effects of the protocol of CDV combined with CiE as pre-operative chemotherapy in high-risk childhood neuroblastoma]. Feng C, Tang SQ, Wang JW, Liu Y, Yang G. Zhongguo Dang Dai Er Ke Za Zhi; 2009 Nov 15; 11(11):885-7. PubMed ID: 20113653 [Abstract] [Full Text] [Related]
10. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery. Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R. Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):427-36. PubMed ID: 15380576 [Abstract] [Full Text] [Related]
11. Poor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: the International Society of Paediatric Oncology European Neuroblastoma Experience. Canete A, Gerrard M, Rubie H, Castel V, Di Cataldo A, Munzer C, Ladenstein R, Brichard B, Bermúdez JD, Couturier J, de Bernardi B, Pearson AJ, Michon J. J Clin Oncol; 2009 Mar 01; 27(7):1014-9. PubMed ID: 19171715 [Abstract] [Full Text] [Related]
13. N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age. Cheung NK, Kushner BH, LaQuaglia M, Kramer K, Gollamudi S, Heller G, Gerald W, Yeh S, Finn R, Larson SM, Wuest D, Byrnes M, Dantis E, Mora J, Cheung IY, Rosenfield N, Abramson S, O'Reilly RJ. Med Pediatr Oncol; 2001 Jan 01; 36(1):227-30. PubMed ID: 11464891 [Abstract] [Full Text] [Related]
14. Evaluation of patients with advanced neuroblastoma surviving more than 5 years after initiation of an intensive Japanese protocol: a report from the Study Group of Japan for Treatment of Advanced Neuroblastoma. Iwafuchi M, Utsumi J, Tsuchida Y, Kaneko M, Matsuyama S, Ohnuma N, Taguchi N, Mugishima H, Yokoyama J, Sasaki S, Yoshioka A, Nagahara N, Fukuzawa M, Suita S. Med Pediatr Oncol; 1996 Dec 01; 27(6):515-20. PubMed ID: 8888810 [Abstract] [Full Text] [Related]
15. Localised and unresectable neuroblastoma in infants: excellent outcome with primary chemotherapy. Neuroblastoma Study Group, Société Française d'Oncologie Pédiatrique. Rubie H, Plantaz D, Coze C, Michon J, Frappaz D, Baranzelli MC, Chastagner P, Peyroulet MC, Hartmann O, Neuroblastoma Study Group, Société Française d'Oncologie Pédiatrique. Med Pediatr Oncol; 2001 Jan 01; 36(1):247-50. PubMed ID: 11464897 [Abstract] [Full Text] [Related]
17. Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma. Chi SN, Gardner SL, Levy AS, Knopp EA, Miller DC, Wisoff JH, Weiner HL, Finlay JL. J Clin Oncol; 2004 Dec 15; 22(24):4881-7. PubMed ID: 15611503 [Abstract] [Full Text] [Related]
18. Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience. Fangusaro J, Finlay J, Sposto R, Ji L, Saly M, Zacharoulis S, Asgharzadeh S, Abromowitch M, Olshefski R, Halpern S, Dubowy R, Comito M, Diez B, Kellie S, Hukin J, Rosenblum M, Dunkel I, Miller DC, Allen J, Gardner S. Pediatr Blood Cancer; 2008 Feb 15; 50(2):312-8. PubMed ID: 17668858 [Abstract] [Full Text] [Related]
19. Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue. Zacharoulis S, Levy A, Chi SN, Gardner S, Rosenblum M, Miller DC, Dunkel I, Diez B, Sposto R, Ji L, Asgharzadeh S, Hukin J, Belasco J, Dubowy R, Kellie S, Termuhlen A, Finlay J. Pediatr Blood Cancer; 2007 Jul 15; 49(1):34-40. PubMed ID: 16874765 [Abstract] [Full Text] [Related]
20. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. Ferrari S, Smeland S, Mercuri M, Bertoni F, Longhi A, Ruggieri P, Alvegard TA, Picci P, Capanna R, Bernini G, Müller C, Tienghi A, Wiebe T, Comandone A, Böhling T, Del Prever AB, Brosjö O, Bacci G, Saeter G, Italian and Scandinavian Sarcoma Groups. J Clin Oncol; 2005 Dec 01; 23(34):8845-52. PubMed ID: 16246977 [Abstract] [Full Text] [Related] Page: [Next] [New Search]